CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 148 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,573,000 | +36.2% | 10,300,000 | 0.0% | 2.40% | +56.5% |
| Q2 2023 | $112,785,000 | +25.6% | 10,300,000 | 0.0% | 1.53% | +14.9% |
| Q1 2023 | $89,816,000 | +39.1% | 10,300,000 | 0.0% | 1.33% | +38.0% |
| Q4 2022 | $64,581,000 | +79.1% | 10,300,000 | 0.0% | 0.96% | +44.9% |
| Q3 2022 | $36,050,000 | +18.6% | 10,300,000 | 0.0% | 0.67% | +11.0% |
| Q2 2022 | $30,385,000 | -5.1% | 10,300,000 | 0.0% | 0.60% | +2.6% |
| Q1 2022 | $32,033,000 | -8.0% | 10,300,000 | 0.0% | 0.58% | -1.3% |
| Q4 2021 | $34,814,000 | -7.4% | 10,300,000 | 0.0% | 0.59% | +0.3% |
| Q3 2021 | $37,595,000 | -16.3% | 10,300,000 | 0.0% | 0.59% | -24.3% |
| Q2 2021 | $44,908,000 | -4.0% | 10,300,000 | 0.0% | 0.78% | -3.3% |
| Q1 2021 | $46,762,000 | -20.9% | 10,300,000 | 0.0% | 0.81% | -20.6% |
| Q4 2020 | $59,122,000 | -20.7% | 10,300,000 | 0.0% | 1.02% | -3.9% |
| Q3 2020 | $74,572,000 | +307.0% | 10,300,000 | +96.2% | 1.06% | +192.5% |
| Q2 2020 | $18,323,000 | +125.1% | 5,250,000 | -4.5% | 0.36% | +31.6% |
| Q1 2020 | $8,140,000 | -24.5% | 5,500,000 | 0.0% | 0.28% | -13.2% |
| Q4 2019 | $10,780,000 | -22.0% | 5,500,000 | +103.7% | 0.32% | -45.1% |
| Q3 2019 | $13,824,000 | -28.5% | 2,700,000 | 0.0% | 0.58% | -13.6% |
| Q2 2019 | $19,332,000 | +100.8% | 2,700,000 | +272.4% | 0.67% | +60.6% |
| Q1 2019 | $9,628,000 | -44.1% | 725,000 | -43.5% | 0.42% | -37.2% |
| Q2 2018 | $17,209,000 | – | 1,282,374 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |